|
31
|
Product specific BE guideline |
Raloxifene Tablets_學名藥生體相等性試驗指導原則
|
2025-09-24 |
|
32
|
Product specific BE guideline |
Gefitinib Tablet _生體相等性試驗指導原則
|
2025-09-24 |
|
33
|
Product specific BE guideline |
Imatinib Mesylate Tablets_生體相等性試驗指導原則
|
2025-09-24 |
|
34
|
Product specific BE guideline |
Lidocaine Prilocaine_生體相等性試驗指導原則
|
2025-09-24 |
|
35
|
Product specific BE guideline |
Lurasidone hydrochloride tablet_生體相等性試驗指導原則_V2(新增QA)
|
2025-09-24 |
|
36
|
Product specific BE guideline |
Metformin+Glimepiride tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
37
|
Product specific BE guideline |
Montelukast sodium Chewable Tablet, 5 mg, 4 mg_生體相等性試驗指導原則
|
2025-09-24 |
|
38
|
Product specific BE guideline |
Montelukast sodium Oral Granules 4 mg_生體相等性試驗指導原則
|
2025-09-24 |
|
39
|
Product specific BE guideline |
Montelukast sodium Tablets_生體相等性試驗指導原則
|
2025-09-24 |
|
40
|
Product specific BE guideline |
Nebivolol hydrochloride tablet_生體相等性試驗指導原則
|
2025-09-24 |
